Oncostatin M is a potent stimulator of α1-antitrypsin secretion in lung epithelial cells: Modulation by transforming growth factor-β and interferon-γ

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 4, 1998, Pages 511-520

  Boutten, Anne ^a   Venembre, Philippe ^b   Seta, Nathalie ^b   Hamelin, Jocelyne ^b   Aubier, Michel ^b   Durand, Geneviève ^b   Dehoux, Monique S ^b  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; LEUKOCYTE ELASTASE INHIBITOR; ONCOSTATIN M; OSM PROTEIN, HUMAN; PEPTIDE; PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CELL CULTURE; CELL LINE; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; HUMAN; LIVER; LUNG; LUNG ALVEOLUS MACROPHAGE; MALE; METABOLISM; RAT; SECRETION; SPRAGUE DAWLEY RAT; TIME;

ALPHA 1-ANTITRYPSIN; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; CELL LINE; CULTURE MEDIA, CONDITIONED; CYTOKINES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; INTERFERON TYPE II; LIVER; LUNG; MACROPHAGES, ALVEOLAR; MALE; ONCOSTATIN M; PEPTIDES; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032037476     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.4.2772     Document Type: Article

References (43)

1. Gadek, J. E., G. A. Fells, R. L. Zimmerman, S. I. Rennard, and R. G. Crystal. 1981. Antielastases of the human alveolar structures: implications for the protease-antiprotease theory of emphysema. J. Clin. Invest. 68:889-898.
2. Hood, J. M., L. Koep, R. F. Peters, P. J. Schroter, R. Weil, A. G. Redeker, and T. E. Starzl. 1980. Liver transplantation for advanced liver disease with alpha 1-antitrypsin. N. Engl. J. Med. 302:272-275.
3. 1-antitrypsin by a human hepatoma cell line. Hepatology 4:235-241.
4. 1-proteinase inhibitor gene in human monocytes and macrophages. Proc. Natl. Acad. Sci. USA 82:795-799.
5. 1-proteinase inhibitor in human monocytes and macrophages. J. Clin. Invest. 77:1207-1213.
6. 1-antitrypsin. Blood 77:2724-2730.
7. 1-antitrypsin and CD30 expressions occur in parallel in activated T cells. Clin. Exp. Immunol. 88: 543-547.
8. 1-antitrypsin gene is expressed in a human intestinal epithelial cell line. J. Biol. Chem. 264: 9485-9490.
9. Molmenti, E. P., T. Ziambaras, and D. H. Perlmutter. 1993. Evidence for an acute phase response in human intestinal epithelial cells. J. Biol. Chem. 268:14116-14124.
10. Thompson, A. B., R. A. Robbins, D. J. Romberger, J. H. Sisbon, J. R. Spurzen, H. Teschler, and S. Rennard. 1995. Immunological function of the pulmonary epithelium. Eur. Respir. J. 8:127-149.
11. 1-antitrypsin by alveolar epithelial cells. FEBS Lett. 346:171-174.
12. Baumann, H., and J. Gauldie. 1994. The acute phase response. Immunol. Today 15:74-80.
13. 1protease inhibitor in human hepatoma cell lines. Inflammation 14:485-497.
14. Magielska-Zero, D., J. Bereta, B. Czuba-Pelech, W. Pajdak, J. Gauldie, and A. Koj. 1988. Inhibitory effect of human recombinant interferon gamma on synthesis of acute phase proteins in human hepatoma Hep G2 cells stimulated by leukocyte cytokines. TNF-α and IFN-β2/BSF-2 IL-6. Biochem. Int. 17:17-23.
15. Baumann, H., C. Richards, and J. Gauldie. 1987. Interaction between hepatocyte-stimulating factors, interleukin-1 and glucocorticoids for regulation of acute phase proteins in human hepatoma (Hep-G2) cells. J. Immunol. 139:4122-4128.
16. 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J. Clin. Invest. 84:138-144.
17. 1-antichymotrypsin synthesis in cells of epithelial origin. FEBS Lett. 359: 262-266.
18. 1-antichymotrypsin expression in human lung-derived epithelial cells. J. Clin. Invest. 95:2729-2733.
19. Dehoux, M., A. Boutten, J. Ostinelli, N. Seta, M. C. Dombret, B. Crestani, M. Deschenes, J. L. Trouillet, and M. Aubier. 1994. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med. 150:710-716.
20. Anegon, I., J. F. Moreau, A. Godard, Y. Jacques, M. A. Peyrat, M. M. Hallet, G. Wong, and J. P. Soulillou. 1990. Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. Cell Immunol. 130:50-65.
21. Rose, T. M., and A. G. Bruce. 1991. Oncostatin M is a member of a cytokine family which includes leukemia inhibitory factor, granulocyte colony-stimulating factor and interleukin-6. Proc. Natl. Acad. Sci. USA 88:8641-8645.
22. Crestani, B., C. Rolland, A. Petiet, N. Colas-Linhart, and M. Aubier. 1993. Cell surface carbohydrates modulate neutrophil adherence to alveolar type II cells in vitro. Am. J. Physiol. 264 (Lung Cell Mol. Physiol. 8):L391-L400.
23. Crestani, B., P. Cornillet, M. Dehoux, C. Rolland, M. Guenounou, and M. Aubier. 1994. Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. J. Clin. Invest. 94:731-740.
24. Yoshimura, A., M. Ichihara, I. Kinjyo, M. Moriyama, N. G. Copeland, J. G. Debra, N. A. Jenkins, T. Hara, and A. Miyahima. 1996. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J. 15:1055-1063.
25. Labarca, C., and K. Paigen. 1980. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:344-352.
26. 1-proteinase inhibitor form and function in lung lavage fluid from healthy subjects. Biol. Chem. Hoppe-Seyler 369:1065-1074.
27. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by a guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
28. 1-antitrypsin-deficient individuals. J. Clin. Invest. 77:1952-1961.
29. Sallenave, J. M., J. Shulmann, J. Crossley, M. Jordana, and J. Gauldie. 1994. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ES1/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11: 733-741.
30. Richards, C. D., T. J. Brown, M. Shoyab, H. Baumann, and J. Gauldie. 1992. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 148: 1731-1736.
31. Abbinante-Nissen, J., M. Joan, L. G. Simpson, and G. D. Leikauf. 1995. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 268:L601-L606.
32. 1-proteinase inhibitor synthesis in human cells of monocytic origin. Biochem. Biophys. Res. Commun. 208:216-222.
33. Piquet-Pellorce, C., L. Grey, A. Mereau, and J. K. Heath. 1994. Are LIF and related cytokines functionally equivalent? Experiment. Cell. Res. 213: 340-347.
34. Gearing, D. P., M. R. Coumeau, D. J. Friend, S. D. Gimpel, C. J. Thut. J. McGourty, K. K. Brasher, J. A. King, S. Gillis, H. Mosley, S. F. Ziegler, and D. Cosman. 1442. The IL-6 signal transducer, gp 130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434-1437.
35. Thoma, B., T. A. Bird, D. J. Friend, D. P. Gearing, and S. K. Dower. 1994. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shaved receptor complexes. J. Biol. Chem. 269:6215-6222.
36. Mosley, B., C. Delmus, D. Friend, N. Bodini, B. Thoma, L. Park, and D. Cosman. 1995. Characterization of oncostatin-M receptor complexes and identification of distinct signaling domains in type II receptors. Cytokine 7:642, A288, (Abstr.)
37. Campos, S. P., Y. Wang, A. Koj, and H. Baumann, 1993. Divergent transforming growth factor β effects on II.-6 regulation of acute phase plasma proteins in rat hepatoma cells. J. Immunol. 151:7128-7137.
38. Assoian, R. K., B. E. Fleurdelys, and H. C. Stevenson. 1987. Expression and secretion of type-β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84:6020-6024.
39. Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders, A. Kemp, O. H. Bereznay, and A. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5:155-162.
40. Yamauchi, K., Y. Martinet, P. Basset, G. A. Fells, and R. G. Crystal. 1998. High levels of transforming growth factor-β are present in the epithelial lining fluid of the normal human lower respiratory tract. Am. Rev. Respir. Dis. 137:1360-1363.
41. Falus, A., K. G. Fecher, E. Wamcz, M. Brozik, G. Fust, T. Hidvegi, T. Feher, and K. Meretey. 1990. Hormonal regulation of complement biosynthesis in human cell lines-I. Androgens and gamma-interferon stimulate the biosynthesis and gene expression of C1 inhibitor in human cell lines U937 and HepG2. Mol. Immunol. 27:191-195.
42. Baumann, H. K. A. Won, and G. P. Jahreis. 1989. Human hepatocyle-stimulating factor-III and interleukin-6 are structurally and immunologically distinct but regulate the production of the same acute phase plasma proteins. J. Biol. Chem. 264:8046-8051.
43. 1-proteinase inhibitor by lung derived epithelial cells. J. Biol. Chem. 272:8250-8255.